Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 11101-11110 of 12013

Page
per page
  1. 7-Methoxycoumarin-4-acetyl-P-L-G-L-β-(2,4-dinitrophenylamino)A-R amide
    A1500 7-Methoxycoumarin-4-acetyl-P-L-G-L-β-(2,4-dinitrophenylamino)A-R amide
    Summary: Substrate of matrix metalloproteinases assay
      ≥48.7 mg/mL
      insoluble in H2O
  2. CA 074
    A1926 CA 074
     2 Citation
    Target: Cathepsins
    Summary: Cathepsin B inhibitor
      ≥19.17 mg/mL
  3. HBcAg [Hepatitis B virus] (18-27)
    A1140 HBcAg [Hepatitis B virus] (18-27)
    Summary: Indicator of active viral replication
      ≥115.5 mg/mL
  4. Carfilzomib (PR-171)
    A1933 Carfilzomib (PR-171)
     10 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, epoxomicin analog
      ≥35.99 mg/mL
  5. Cyclo (-RGDfK)
    A8164 Cyclo (-RGDfK)
     6 Citation
    Summary: Inhibitor of αvβ3 integrin
      ≥30.19 mg/mL
  6. (E)-2-Decenoic acid
    A3104 (E)-2-Decenoic acid
    Summary: Fatty acid identified in royal jelly
  7. 1alpha, 25-Dihydroxy VD2-D6
    A3111 1alpha, 25-Dihydroxy VD2-D6
    Summary: Deuterated form of vitamin D
      Soluble in DMSO
  8. 3,3'-Diindolylmethane
    A3118 3,3'-Diindolylmethane
    Summary: Anticancer and antineoplastic agent
      insoluble in H2O; ≥11.15 mg/mL
  9. 360A iodide
    A3120 360A iodide
    Summary: G-quadruplex structures inhibitor
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO
  10. 5-R-Rivaroxaban
    A3126 5-R-Rivaroxaban
    Target: Factor Xa
    Summary: Factor Xa (FXa) inhibitor
      ≥20.85 mg/mL

Items 11101-11110 of 12013

Page
per page